Lord, Abbett & Co. LLC Homology Medicines, Inc. Transaction History

Lord, Abbett & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $4.61 Million - $6.96 Million	-312,435 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.35 - $30.34 $2.22 Million - $3.67 Million	-121,057 Reduced 27.93%	312,435 $6.11 Million
Q1 2019 May 15, 2019	BUY	$19.76 - $29.57 $3.08 Million - $4.6 Million	155,692 Added 56.04%	433,492 $12 Million
Q4 2018 Feb 14, 2019	SELL	$18.39 - $26.3 $1.8 Million - $2.57 Million	-97,907 Reduced 26.06%	277,800 $6.21 Million
Q3 2018 Nov 14, 2018	BUY	$15.54 - $22.86 $857,497 - $1.26 Million	55,180 Added 17.22%	375,707 $8.59 Million
Q2 2018 Aug 14, 2018	BUY	$16.49 - $21.55 $1.99 Million - $2.6 Million	120,527 Added 60.26%	320,527 $6.54 Million
Q1 2018 May 15, 2018	BUY	$18.66 - $18.7 $3.73 Million - $3.74 Million	200,000 New	200,000 $3.74 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.